pharma · Melanoma · Ovarian Cancer
Sandoz (Japan)
Sandoz Pty Ltd
Sandoz Pty is a pharma organization headquartered in AU. Primary therapeutic focus areas include Melanoma, Ovarian Cancer, Asthma. NovaPharmaNews links 4 clinical program(s), 8 drug profile(s), and 0 patent record(s) to
Basel, CH HQ
17,495 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- Basel, CH
- Employees
- 17,495
- Programs
- 4
- Drugs
- 22
- Patents
- 0
JPB898 (Induction and Maintenance)
Phase 3 · small molecule · Melanoma
JPB898 (Induction and Maintenance) for Melanoma is a Phase 3 program (small_molecule) at Sandoz Pty Ltd with 1 ClinicalTrials.gov record(s).
Internal code CJPB898A12301
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Sandoz Pty Ltd
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Melanoma
- Status
- terminated
- Trials
- 1